This document is designed to help you prepare an abstract that meets the criteria for FIP congresses. It is intended to be read alongside the call for abstracts, which specifies the congress topic areas, and applies to abstracts for oral presentations and posters.
An abstract is a short statement that gives the reader a comprehensive yet concise understanding of your work. Your work could be research, such as a study or clinical trial, or a new or unique service, programme, theory or resource.
An abstract is an opportunity to make your work known, inform practice and/or education, and to establish connections with others in your field of interest. It should tell readers what you are going to present and interest them in learning more about your work — they may decide to attend your presentation, visit your poster or contact you based on it.
Your abstract will have difference audiences:
· Congress delegates (pharmacists, pharmaceutical scientists, students, educators, policy-makers and researchers) use abstracts to select which sessions to attend.
· Reviewers will assess the quality of your abstract and recommend its acceptance (and whether the work should be presented orally or as a poster) or rejection.
· Journal editors use abstracts to look for papers to encourage for publication.
· People who can’t attend the congress access abstracts online.
Your abstract should contain information under the following subheadings :
· Background information (Why is your work important? Does it fill any gaps in knowledge or research? What is the context?)
· Purpose (What are the objectives? You may include a short statement of your hypothesis.)
· Method (Explain your methods, such as study design. What was done, by whom, how and where? What measurements were taken and how were the data managed?)
· Results (What did you find, discover or achieve? Not just in subjective terms, but also in the form of data. How significant were your findings?)
· Conclusion (What were your overall findings? What do they mean? How could the methods be improved? Is this work part of a bigger piece of research or strategy? What are the suggestions for future work?)
· Topic area (Refer to the areas listed in the call for abstracts and select the most appropriate so that the congress organisers can place your abstract in the appropriate session.)
· By submitting your work to Arab Pharmacists Union ( APU), you consent to have authors’ names, affiliation and biographical material used in connection with the publication of your work.
· Author(s) represent(s) and warrant(s) that he/she/they is/are the sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party. The submitter affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders, and that all statements declared as facts are based on thorough examination and investigation for accurateness.
· Submitted abstracts should not have been published in any other journals and/or online publications nor presented at any previous international congress. However, former presentation at national meetings does not disqualify.
· Submitted abstracts must report new information not previously published or presented at an international scientific meeting prior to the Congress. Note that abstracts previously presented at international meetings will not be accepted unless there is a substantial update of data..
· The content belongs to the author(s). However, if the abstract is accepted the submitter agrees, on behalf of all co-authors, to transfer and assign to the APU the rights to edit, publish, reproduce, distribute copies and prepare derivative works such as press releases. This includes use in indexes or search databases in print, electronic, or other media.
· Author(s) retain(s) the right, after presentation at the Congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits, provided said use does not imply the endorsement of APU.
· The submitter signs for all co-authors. He/she accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.
Rules for content and structure
· Abstracts must be in British English. (If you are not a native English speaker, you are advised to have your writing reviewed by a native English speaker before submission.)
· Abstracts should preferably contain previously unpublished results.
· Abstracts must be no more than 1,700 characters (including spaces), excluding the title and excluding the name(s) and institutes/companies of the authors and co-authors.
· All co-authors must be listed.
· All listed co-authors must have reviewed the abstract and accepted responsibility for its contents.
· Abstract titles should not include phone numbers, email or website addresses.
· No images, tables or graphs are permitted in the abstract.
· Non-proprietary (generic) drug names must be used wherever possible.
· Active promotion of commercial entities, products or services is not permitted.